Get the Daily Brief
Latest Biotech News
Emerging Therapies Targeting Pain and Obesity Take Flight
Following Vertex Pharmaceuticals’ landmark approval of a selective sodium channel blocker addressing acute pain, SiteOne Therapeutics has garnered significant investment and agreed to a potential...
Novel Cancer Immunotherapies and Biomarkers Surface in Clinical Research
Recent studies uncover various innovations improving cancer therapy and diagnosis. Biokin achieved a Phase 3 success with a bispecific antibody-drug conjugate licensed to Bristol Myers Squibb. New...
AI and Automation Innovate Neuroscience and Neurodegenerative Disease Research
Cutting-edge interdisciplinary efforts are leveraging AI to elucidate and treat neurological disorders. Digital speech biomarker studies quantify levodopa response variability in Parkinson’s...
AbbVie’s $2.1 Billion Bet on In Vivo CAR-T Therapy
AbbVie announced the acquisition of Capstan Therapeutics for up to $2.1 billion, aiming to deepen its exploration of in vivo CAR-T therapies—a promising approach that engineers immune cells...
AI Advances in Cancer Detection and Diagnostics
Recent breakthroughs illustrate AI’s expanding role in oncology, with institutions developing models for early cancer detection and enhanced diagnostic accuracy. The University of Sharjah unveiled...
Psychedelic Therapies Gain Mid-Stage Clinical Momentum
Beckley Psytech and Atai Life Sciences reported positive Phase 2b results for the psychedelic compound BPL-003 (intranasal mebufotenin) in treatment-resistant depression, exceeding efficacy...
Genetic Damage from Chemotherapy Illuminates Safer Treatment Paths
Groundbreaking studies from the Wellcome Sanger Institute and collaborators have characterized distinct mutational signatures induced by diverse chemotherapy drugs on healthy blood cells,...
New Agents and Strategies in Obesity and Metabolic Disease
Innovative approaches to obesity treatment are emerging, including Syntis Bio’s novel intestinal coating technology mimicking gastric bypass effects, funded with $38 million to advance clinical...
Regulatory Shifts and Industry Financing Highlights
Significant industry movements include Sage Therapeutics planning layoffs of most staff following acquisition by Supernus Pharmaceuticals, underscoring volatility in neuropharma. Imagene AI raised...
Innovations in Gene Editing and RNA Therapeutics
Technological advances are accelerating gene and RNA-based therapies. Researchers demonstrated a near-infrared light activatable CRISPR system enabling precise spatiotemporal genome editing....
Single-Atom and Molecular Advances in Cancer Therapy
Cutting-edge cancer research highlights include the use of single-atom engineering to create radiotherapy-activated immune prodrugs that boost targeted immune responses. Studies revealed...
Climate Change and Environmental Impact on Health and Agriculture
New studies shed light on environmental challenges affecting health and food systems. Research revealed gut bacteria bioaccumulate harmful PFAS pollutants, presenting novel microbiome-targeted...
AbbVie Buys In Vivo CAR-T Developer Capstan for $2.1 Billion
AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics, a startup advancing in vivo CAR-T therapies aimed at autoimmune diseases and cancer. Capstan’s lead candidate CPTX2309, an...
Phase 2b Trial Shows Psychedelic Mebufotenin Cuts Depression Symptoms
Beckley Psytech and Atai Life Sciences reported positive Phase 2b trial results for BPL-003, an intranasal formulation of the psychedelic mebufotenin, significantly reducing symptoms in...
New Chemotherapy Mutational Signatures Reveal Long-Term Risks
A landmark study led by the Wellcome Sanger Institute and University of Cambridge has systematically characterized DNA damage patterns caused by various chemotherapy drugs in healthy blood cells....
Moderna’s mRNA Flu Vaccine Shows Superior Efficacy in Phase 3 Trial
Moderna announced that its mRNA-based seasonal influenza vaccine, mRNA-1010, demonstrated a 27% reduction in influenza-like illness compared to a standard marketed vaccine in individuals aged 50...
Machine Learning Models Enhance Cancer Detection and Prognosis
Recent advances in artificial intelligence have produced models capable of improving diagnosis and outcome prediction in oncology. This includes an AI platform for early pancreatic cancer...
Parkinson’s Disease Research Yields Molecular and Therapeutic Insights
Multiple studies reveal new understanding of Parkinson’s disease (PD) mechanisms and interventions. These include digital speech biomarkers measuring levodopa effects, enzyme inhibition restoring...
Advances in Sustainable and Biomedical Materials Science
Innovative research is increasing the ease and scope of creating sustainable biomaterials and medical textiles. Developments include cellulose-derived biodegradable foams, breathable protective...
Genetic and Molecular Targets Propel Cancer and Immunotherapy Research
Cutting-edge studies identify novel molecular mechanisms and therapeutic targets across cancer and immunology fields. Topics include DLK1 as an immunotherapy target in adrenocortical carcinoma,...